At the 2025 European Society of Cardiology (ESC) Congress, Anjali Vaidya, MD, FACC, FASE, FACP, Director of the Advanced Pulmonary Hypertension, Right Heart Failure and CTEPH program at Temple University Hospital, presented new data on the effect of sotatercept on right ventricular function and structure. AJMC highlighted the data which revealed sotatercept's significant benefits for right ventricular function and tricuspid regurgitation in pulmonary arterial hypertension.